Must each incoming or outgoing shipment in wholesale be inspected for contamination?

In the context of wholesale pharmaceutical distribution, it is essential to ensure the safety and integrity of medications throughout the supply chain. This necessitates that each incoming or outgoing shipment undergoes inspection for contamination. This practice is in accordance with regulatory standards designed to protect public health by preventing the distribution of potentially harmful products.

Regular inspections help identify any risks of contamination that could arise during transportation or handling, ensuring that medications are safe for patient use. By mandating inspection for every shipment, the process emphasizes accountability and vigilance within the distribution network, which is crucial for maintaining the integrity of the pharmaceutical supply chain. This requirement is not limited to high-risk medications or contingent upon receiving complaints; it applies universally to all shipments in wholesale distribution to mitigate risks before they can impact consumers.